Literature DB >> 15666800

Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone.

Kenichi Yokota1, Hirotaka Shibata, Sakiko Kobayashi, Noriko Suda, Ayano Murai, Isao Kurihara, Ikuo Saito, Takao Saruta.   

Abstract

The ubiquitin-proteasome pathway regulates the turnover of many nuclear hormone receptors, such as the estrogen receptor. For estrogen receptor, proteasome inhibition decreases ligand-mediated transcription. We provide evidence that the mineralocorticoid receptor (MR) is degraded by the ubiquitin-proteasome pathway in a ligand-dependent manner and that proteasomal inhibition results in increased accumulation of the MR with enhancement of transcriptional response to aldosterone. Examination of the primary sequence of human and rat MR has identified two candidate PEST degradation motifs. Mutation of lysine 715 and/or 367 within this PEST element failed to prevent degradation of MR protein or transcriptional activity mediated by aldosterone, indicating that other lysine residues are targeted by proteasomal degradation of MR. These findings demonstrate a coupling between MR up-regulation and transcriptional hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15666800     DOI: 10.1081/erc-200043783

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  7 in total

1.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

2.  RNA sequencing of kidney distal tubule cells reveals multiple mediators of chronic aldosterone action.

Authors:  Søren Brandt Poulsen; Kavee Limbutara; Robert A Fenton; Trairak Pisitkun; Birgitte Mønster Christensen
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

Review 3.  Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.

Authors:  Kyle T Helzer; Christopher Hooper; Shigeki Miyamoto; Elaine T Alarid
Journal:  J Mol Endocrinol       Date:  2015-05-05       Impact factor: 5.098

4.  Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.

Authors:  Larbi Amazit; Florian Le Billan; Peter Kolkhof; Khadija Lamribet; Say Viengchareun; Michel R Fay; Junaid A Khan; Alexander Hillisch; Marc Lombès; Marie-Edith Rafestin-Oblin; Jérôme Fagart
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

5.  Marinobufagenin interferes with the function of the mineralocorticoid receptor.

Authors:  Carolyn L Smith; Qiang He; Luping Huang; Estrella Foster; Jules B Puschett
Journal:  Biochem Biophys Res Commun       Date:  2007-03-26       Impact factor: 3.575

Review 6.  Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications.

Authors:  Ondrej Zenata; Radim Vrzal
Journal:  Oncotarget       Date:  2017-05-23

Review 7.  Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone.

Authors:  N Muñoz-Durango; A Vecchiola; L M Gonzalez-Gomez; F Simon; C A Riedel; C E Fardella; A M Kalergis
Journal:  Biomed Res Int       Date:  2015-09-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.